PharmaShots | Incisive News in 3 Shots

Subscribe Now

Rocket

Rocket Reports the US FDA Acceptance of BLA for RP-L201 (marnetegragene autotemcel) to Treat Severe Leukocyte Adhesion Deficiency-I

Rocket Reports the US FDA Acceptance of BLA for RP-L201 (marnetegragene autotemcel) to Treat Severe Leukocyte Adhesion Deficiency-...

October 3, 2023

Rocket to Acquire Renovacor for ~$53M

Rocket to Acquire Renovacor for ~$53M

September 20, 2022

Rocket Presents Results of RP-L201 in the P-II Trial for the Treatment of Severe Leukocyte Adhesion Deficiency-I at ASGCT 2022

Rocket Presents Results of RP-L201 in the P-II Trial for the Treatment of Severe Leukocyte Adhesion Deficiency-I at ASGCT 2022

May 19, 2022

PharmaShots Weekly Snapshots (August 16 - 20, 2021)

PharmaShots Weekly Snapshots (August 16 - 20, 2021)

August 20, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us